Vanja Lazarevic
Experimental Immunology Branch
The Center for Cancer Research
United States of America
Biography
B.Sc., Microbiology, University of Nottingham, Nottingham, UK Ph.D., Molecular Virology and Microbiology, University of Pittsburgh, Pittsburgh, PA Postdoctoral Fellow, Immunology Senior Research Associate, Laboratory of Dr. Laurie H. Glimcher, Harvard School of Public Health, Boston, MA
Research Interest
Immunology
Publications
-
Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, et al. (2011) Transcription factor T-bet represses Th17 differentiation by preventing Runx1-mediated activation of the RORgt gene. Nat. Immunol. 12: 306-313.
-
Staton T, Lazarevic V, Jones D, Lanser A, Takagi T, et al. (2011) Dampening of death pathways by Schnurri 2 is essential for T cell development. Nature. 472: 105-109.
-
Staton T, Lazarevic V, Jones D, Lanser A, Takagi T, et al. (2011) Dampening of death pathways by Schnurri 2 is essential for T cell development. Nature. 472: 105-109.
-
Lazarevic V, Glimcher LH (2011) T-bet in disease. Nat. Immunol. 12: 597-606.
-
Lazarevic V, Glimcher LH, Lord GM (2013) T-bet: a bridge between innate and adaptive immunity. Nat. Rev. Immunol. 13: 777-789.
-
Wang Y, Godec J, Ben-Aissa K, Cui K, Zhao K, et al. (2014) The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells. Immunity. 40: 355-366.
